1. INSERM U1065, Mediterranean Centre for Molecular Medicine (C3M), Team 4 Inflammation, Cancer, Cancer Stem Cells, Nice, France;
2. Faculté de Médecine, Université de Nice Sophia Antipolis, Nice, France;
3. INSERM U1065, C3M, Team 3, Regulation of caspase-dependent and -independent cell deaths, Nice, France;
4. Département d’Onco-Hématologie, Institut Paoli-Calmette, Marseille, France;
5. Team RESIST@ML–Chemoresistance, Stem Cells & Metabolism in AML, Cancer Research Center of Toulouse, Unité Mixte de Recherche Médicale (UMR) 1037, Toulouse, France;
6. Institut Paoli-Calmettes, Aix-Marseille Université, Marseille, France;
7. Centre National de la Recherche Scientifique, UMR725, Marseille, France;
8. Centre de Recherche en Cancérologie de Marseille, TrGET Platform, INSERM, U1068, Marseille, France; and
9. INSERM U1065, C3M, Microscopy Core Facility, Nice, France